1,957 Shares in MKS Inc. $MKSI Bought by Maxi Investments CY Ltd

Maxi Investments CY Ltd bought a new stake in shares of MKS Inc. (NASDAQ:MKSI) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,957 shares of the scientific and technical instruments company’s stock, valued at approximately $870,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of MKS by 3.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock valued at $21,434,000 after purchasing an additional 9,170 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in shares of MKS by 63.4% during the second quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company’s stock valued at $83,000 after purchasing an additional 325 shares in the last quarter. First Trust Advisors LP increased its holdings in shares of MKS by 3,545.6% in the second quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company’s stock worth $14,036,000 after purchasing an additional 137,392 shares during the last quarter. Cerity Partners LLC bought a new stake in shares of MKS in the second quarter worth about $1,676,000. Finally, AXA S.A. lifted its position in shares of MKS by 22.8% in the second quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company’s stock worth $2,907,000 after buying an additional 5,430 shares in the last quarter. 99.79% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CEO John Tseng-Chung Lee sold 10,000 shares of the stock in a transaction on Friday, August 14th. The stock was sold at an average price of $302.01, for a total transaction of $3,020,100.00. Following the sale, the chief executive officer owned 134,776 shares in the company, valued at approximately $40,703,699.76. This represents a 6.91% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Joseph B. Donahue sold 2,100 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $327.95, for a total value of $688,695.00. Following the completion of the sale, the director owned 10,033 shares of the company’s stock, valued at approximately $3,290,322.35. This represents a 17.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 37,491 shares of company stock worth $12,102,072. Company insiders own 0.57% of the company’s stock.

MKS Stock Performance

MKSI opened at $279.11 on Monday. The firm has a market cap of $18.87 billion, a P/E ratio of 44.52, a P/E/G ratio of 0.59 and a beta of 1.98. MKS Inc. has a 12 month low of $97.50 and a 12 month high of $447.62. The company has a current ratio of 1.14, a quick ratio of 0.72 and a debt-to-equity ratio of 0.85. The stock has a 50-day moving average of $341.95 and a 200 day moving average of $294.68.

MKS (NASDAQ:MKSI) last issued its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.39. MKS had a return on equity of 24.72% and a net margin of 10.15%.The company had revenue of $1.25 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same period in the previous year, the firm posted $1.77 earnings per share. The firm’s revenue for the quarter was up 28.3% on a year-over-year basis. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. As a group, research analysts forecast that MKS Inc. will post 12.96 EPS for the current year.

MKS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Tuesday, August 25th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Tuesday, August 25th. This represents a $1.00 annualized dividend and a dividend yield of 0.4%. MKS’s payout ratio is currently 15.95%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on MKSI shares. Wall Street Zen raised MKS from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. Weiss Ratings raised MKS from a “hold (c)” rating to a “buy (b-)” rating in a research note on Tuesday, August 11th. Citigroup upped their price objective on MKS from $425.00 to $430.00 and gave the stock a “buy” rating in a report on Friday, August 7th. KeyCorp increased their target price on MKS from $360.00 to $475.00 and gave the company an “overweight” rating in a research report on Monday, June 29th. Finally, BMO Capital Markets started coverage on shares of MKS in a research report on Tuesday, June 30th. They issued an “outperform” rating and a $453.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, MKS currently has a consensus rating of “Moderate Buy” and an average price target of $385.00.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high?technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.